. Serum alpha-tocopherol in pregnancies with normal or pathological outcomes. Can. J. Physiol. Pharmacol. 52,[384][385][386][387][388] Results indicate that, in comparison with normal pregnancies, in pregnancies leading to abortions, stillbirths, and congenitally malformed infants, maternal alpha-tocopherol differs both as to serum levels and as to rates of increase during gestation. In women aborting or giving birth to malformed infants, decreases in serum alpha-tocopherol levels were noted in the second trimester. In pregnancies ending in stillbirths, the increases in alphatocopherol levels were slower and significantly lower than in normal pregnancies. Because of the limited number of observations no causal relationships were proposed but the hypothesis of a vitamin basis for congenital deformities appears worth testing. 
Introduction
Human studies that directly relate vitamin E during pregnancy to outcomes of pregnancy are few. Although the literature on this vitamin is voluminous, the interpretation of most of it is limited by the experimental design and methodologies used (Kirman 1958 ; \+'arkany 1958; Goldstein 1956; Tupper et al. 1957) .
Studies in animals have reported that a maternal deficiency in dietary alpha-tocopherol leads to an increased incidence of congenital malformations in the offspring (Cheng 1959; Cheng et al. 1960; Richardson and Hogan 1946; Ferguson et ul. 1957) . The data in man, however, have not been so unequivocal. Research published in the 1940's on alpha-'Presented at the 16th Annual meeting of the Canadian Federation of Biological Societies, June 26-29, 1973, Saskatoon, Saskatchewan. Research is supported in part by grant No. 604-7-797 from the Ministry of Health and Welfare, Ottawa, Canada.
tocopherol as a preventive agent in threatened abortions, miscarriages, or congenital malformations in the newborn were case studies rather than adequately designed therapeutic trials. Later studies in man were conflicting. Some found high serum alpha-tocopherol levels in threatened abortions and premature labor (Lindner et ul. 1967) whereas others found no relationship between pregnancy serum alpha-tocopherol levels and pregnancy outcome in the largest series ever examined (Ferguson et al. 1955) .
In view of the above and because the frequency of severe congenital defects has been found to be unexpectedly high in Quebec (Munan 1973) , it was thought opportune to undertake a longitudinal study to investigate the pattern of biochemical changes in pregnancies having normal or pathological outcomes. Serum alpha-tocopherol has been selected as the main variable to help clarify if there is an association between maternal alpha-tocopherol and con~enital defects in the newResults b o g . In this paper,-levels of alpha-tocopherol in sera of women aborting, or giving birth to malformed newborns or to stillborns are presented and discussed.
Methods
The study group consisted of unselected women seeking prenataI care in the outpatient clinic of the University Hospital Center in Sherbrooke, Quebec.
The majority of women were primipara and in the 21-30 age category with a mean of about 26 years. Though it is recognized that age, parity, and gestation are confounding factors affecting serum alphatocopherol concentrations (Vobecky et ul. 1973 ) no attempt at segregating them in the statistical analyses was made at this time.
Blood samples from non-fasted subjects were taken by routine methods in hospital use. The samples were immediately centrifuged, and the sera separated and stored at low temperatures. Serum alpha-tocopherol determinations were carried out on the day after sampling.
Maternal venous blood was obtained at least three times during pregnancy, if possible in each trimester and in the delivery room, and cord blood was collected at the time of delivery. On the 3rd day after birth, the infant was pricked in the heel. The volume of the serum samples was 0.2 ml for alpha-tocopherol determinations in maternal, cord. and infant capillary blood.
The classical method for tocopherol measurement, namely, the Emmerie-Engel reaction, which measures a number of substances other than tocopherol. was rendered more specific and adapted to large surveys while maintaining its inherent sensitivity (Shapcott er al. 1972) . Serum was mixed with an equal volume of ethanol and 2.5 volumes of petrol ether were added, mixed well, and the supernatant was separated. Extraction with petrol ether was repeated, the two supernates were combined, and the solvent was evaporated in a stream of nitrogen.
The extract was then dissolved in 1 ml ethanol petrol ether and applied to a inicrocolumn of deactivated florisil, which had been washed with petrol ether. The extract was washed through the column with 2 x 1 ml of 25% benzene in petrol ether and finally with 4 >( 1 ml of benzene. The last 3 ml of benzene were collected and dried as above.
The extract was redissolved in about 0.5 ml of ethanol and 0.2 rnl of ferric chloride solution added. Then 0.2 ml of ferrozine solution was added, and the optical density of the mixture read after 4 min at 565 mm.
A standard alpha-tocopherol solution and a blank solution were processed with the sa~nples and used to calculate serum concentrations.
Complete medical and dietary history (including a 7-day dietary diary) was obtained for each woman. Her pregnancy outcome was classified as to whether it was an abortion. a stillbirth, or if congenital malformations were present at birth.
One of the objectives of the study was to establish mean values during the course of normal pregnancy in a population of healthy non-institu tionalized women. In Table 1 are presented serum alpha-tocopherol levels during gestation, at delivery, in cord blood. and in the newborn. The greater number of determinations in the later trimesters was due to the fact that many women first consulted a physician late in pregnancy.
Increases in serum alpha-tocopherol levels during gestation were steady and pronounced. Differences between trimesters were statistically significant at the 1% probability level and varied with age and parity. Values in cord and in newborn blood were considerably lower than that of the mother at delivery or at any time during gestation. It would appear that low serum alpha-tocopherol levels in the newborn are related to the decreases in placental transfer potentials (Gordon et al. 1958 ). These differences in the alpha-tocopherol level of the mother in the cord and in the newborn are widely recognized.
In Table 2 are presented data on serum alpha-tocopherol levels in pregnancies ending with a congenitally malformed live-born. Although the number of pregnancies was too small for definitive conclusions, it does appear that the first trimester mean was high (0.97 mg/100 ml serum), whereas there was a decrease to 0.76 mg/100 ml serum in the second trimester with a return in the third trimester to the values characteristic of this period in normal pregnancy (Table 1 ) . With respect to 
alpha-tocopherol values in cord blood and in
Pregnancies ending in abortions are prethe newborn, it is noted that values in con-sented with their serum alpha-tocopherol levels genitally malformed newborn were lower than in Table 3 . In these women, levels in the first values in the normal group (Table 1) but trimester were above the mean for normal thcse differences were not statistically signifi-pregnancies and this difference was statistically cant.
significant at the 596 level. In Table 4 arc given alpha-tocopherol levels in women giving birth to stillborns usually taking place after the 20th week of gestation. As compared with normals, serum alpha-tocopherol levels in these pregnancies increased during the first and second trimester but dropped in the third and at delivery. Only the difference between third trimester means in women giving birth to normal infants as compared with those ending in stillbirths was statistically significant at the 1% level. Fig. 1 summarizes serum alpha-tocopherol levels in the four groups, namely, pregnancies with normal outcome, womein giving birth to stillborns, women aborting, and women giving birth to congenitally malformed infants. There were two noteworthy differences between normal and pathological prcgnailcies, namely, (i) the mean serunn alpha-tocopherol level during the first trinlcster was nnore elevated in pathological pregnancies and, (ii) the serum alphatocopherol levels gradually increased during a normal pregnancy whereas in pathological pregnancies there was either no increasc or no change.
TABLE 4. Serum alpha-tocopherol (mg/100 ml serum) in mothers of stillborns 
Discussion
In pregnancies with normal outcome, serum alpha-tocopherol levels are known to increase steadily from the first weeks of pregnancy to delivery. This rise was confirmed in the present study. The mean values reported here are somewhat lower than those reported elsewhere (Ferguson et al. 1955; Lindner et al. 1967; Gounelle et ul. 1955) for reasons that have already been discussed (Vobecky et al. 1973) relating to possible differences in analytic techniques and in population characteristics.
Ferguson in 1955 found no significant deviation from normal in plasma tocopherol levels in any of the subgroups of subjects that experienced complications during pregnancy. They concluded that no support could be obtained for the thcsis that tocopherol deficiency accounts for those complications of pregnancy that are encountered in the usual obstetric population. When thus viewed, our results do not contradict those of Ferguson in that we too did not find a deficiency of alphatocopherol in relation to pregnancy outcorncs, at least if one were to assess vitamin deficiencics in terms of plasma levels. The same view had been held earlier by Scrimshaw et al. (1949) who found that thc tocopherol values of women with threatened abortions showed no tendency to be lower than normal.
The present findings nccd not be interpretcd as causally relating alpha-tocopherol to congenital dcfects, to abortions, or to stillbirths. An association, however, is being noted and in the direction opposite to that reported in animal studies and justifying further research.
